Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients.
Antiphospholipid syndrome
Classification criteria
Pregnancy
Severe preeclampsia
Systemic lupus erythematosus
Thrombosis
Journal
Arthritis research & therapy
ISSN: 1478-6362
Titre abrégé: Arthritis Res Ther
Pays: England
ID NLM: 101154438
Informations de publication
Date de publication:
04 05 2021
04 05 2021
Historique:
received:
12
02
2021
accepted:
21
04
2021
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
22
6
2021
Statut:
epublish
Résumé
The criteria for antiphospholipid syndrome (APS) include severe preeclampsia and/or placental insufficiency leading to preterm delivery before 34 weeks of gestation, but this APS manifestation has been rarely studied. Thus, we report a series of severe preeclampsia occurred in patients with APS. We retrospectively analysed data of women with APS (Sydney criteria) who experienced severe preeclampsia with delivery before 34 weeks' gestation between 2000 and 2017 at five French internal medicine departments and one Italian rheumatology unit. The 40 women had a mean age of 30.5 ± 4.6 years at their first episode of preeclampsia; 21 were nulligravid (52.5%), 12 (30%) had already been diagnosed with APS, and 21 (52.5%) had a triple-positive antiphospholipid (aPL) antibody test. Preeclampsia occurred at a median gestational age of 25.5 weeks (IQR 23-29). It was associated with HELLP in 18 cases (45%), eclampsia in 6 (15%), placental abruption in 3 (7.5%), catastrophic APS in 3 (7.5%), and foetal and neonatal death in 11 and 15 cases. Overall, 14 (35%) children survived, born at a median gestational age of 31 weeks. Among other APS criteria, 16 women (40%) experienced at least one thrombosis, 17 (42.5%) an intrauterine foetal death, and 19 (47.5%) at least one episode of HELLP during follow-up (median 5 years, IQR = 2-8). None had three or more consecutive miscarriages. Notably, 12 women (30%) had systemic lupus erythematosus. Severe preeclampsia led to high mortality in the offspring. Almost half of these women experienced other APS features, but not three consecutive miscarriages.
Sections du résumé
BACKGROUND
The criteria for antiphospholipid syndrome (APS) include severe preeclampsia and/or placental insufficiency leading to preterm delivery before 34 weeks of gestation, but this APS manifestation has been rarely studied. Thus, we report a series of severe preeclampsia occurred in patients with APS.
METHODS
We retrospectively analysed data of women with APS (Sydney criteria) who experienced severe preeclampsia with delivery before 34 weeks' gestation between 2000 and 2017 at five French internal medicine departments and one Italian rheumatology unit.
RESULTS
The 40 women had a mean age of 30.5 ± 4.6 years at their first episode of preeclampsia; 21 were nulligravid (52.5%), 12 (30%) had already been diagnosed with APS, and 21 (52.5%) had a triple-positive antiphospholipid (aPL) antibody test. Preeclampsia occurred at a median gestational age of 25.5 weeks (IQR 23-29). It was associated with HELLP in 18 cases (45%), eclampsia in 6 (15%), placental abruption in 3 (7.5%), catastrophic APS in 3 (7.5%), and foetal and neonatal death in 11 and 15 cases. Overall, 14 (35%) children survived, born at a median gestational age of 31 weeks. Among other APS criteria, 16 women (40%) experienced at least one thrombosis, 17 (42.5%) an intrauterine foetal death, and 19 (47.5%) at least one episode of HELLP during follow-up (median 5 years, IQR = 2-8). None had three or more consecutive miscarriages. Notably, 12 women (30%) had systemic lupus erythematosus.
CONCLUSIONS
Severe preeclampsia led to high mortality in the offspring. Almost half of these women experienced other APS features, but not three consecutive miscarriages.
Identifiants
pubmed: 33947469
doi: 10.1186/s13075-021-02518-7
pii: 10.1186/s13075-021-02518-7
pmc: PMC8094564
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
134Références
Lupus. 2020 Nov;29(13):1736-1742
pubmed: 32838621
J Thromb Haemost. 2006 Feb;4(2):295-306
pubmed: 16420554
Lupus. 2018 Oct;27(12):1903-1910
pubmed: 30028257
Obstet Gynecol. 2002 Jan;99(1):159-67
pubmed: 16175681
Curr Opin Obstet Gynecol. 2017 Dec;29(6):397-403
pubmed: 28915160
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Ann Intern Med. 2015 Aug 4;163(3):153-63
pubmed: 26098843
Ann Rheum Dis. 2005 Feb;64(2):273-8
pubmed: 15647435
Arthritis Res Ther. 2018 Nov 06;20(1):249
pubmed: 30400982
Ann Rheum Dis. 2019 Oct;78(10):1296-1304
pubmed: 31092409
Semin Thromb Hemost. 2014 Mar;40(2):163-71
pubmed: 24500573
Ann Rheum Dis. 2017 Mar;76(3):476-485
pubmed: 27457513
Lupus. 2010 Jan;19(1):58-64
pubmed: 19897518
Lupus. 2020 Aug;29(9):1050-1059
pubmed: 32536318
Ann Rheum Dis. 2015 Jun;74(6):1011-8
pubmed: 24464962